Al-Wakeel Yasir B.
Insider CIK 1650691 · MACK CFO and Head of Corp Dev · MXCT Director · NTGN Chief Financial Officer · KRON Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MXCT MAXCYTE, INC. | A Award deriv | 2026-06-17 | 2026-06-22 | 49,579 | — | $0 | 49,579 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award | 2026-06-17 | 2026-06-22 | 30,421 | — | $0 | 80,998 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award deriv | 2025-06-18 | 2025-06-23 | 50,790 | — | $0 | 50,790 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award | 2025-06-18 | 2025-06-23 | 29,210 | — | $0 | 50,577 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award deriv | 2024-06-11 | 2024-06-13 | 40,701 | — | $0 | 40,701 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award | 2024-06-11 | 2024-06-13 | 21,367 | — | $0 | 21,367 | SEC↗ |
| KRON Kronos Bio, Inc. | S Sale | 2023-07-06 | 2023-07-07 | 9,617 | $1.75 | $16.8K | 346,102 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award deriv | 2023-06-22 | 2023-06-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award deriv | 2023-03-20 | 2023-03-21 | 40,000 | — | $0 | 40,000 | SEC↗ |
| KRON Kronos Bio, Inc. | S Sale | 2023-02-24 | 2023-02-24 | 9,026 | $1.74 | $15.7K | 355,719 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award deriv | 2023-02-15 | 2023-02-17 | 208,367 | — | $0 | 208,367 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award | 2023-02-15 | 2023-02-17 | 138,911 | — | $0 | 364,745 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award deriv | 2022-07-25 | 2022-07-27 | 40,000 | — | $0 | 40,000 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award | 2022-07-25 | 2022-07-27 | 53,600 | — | $0 | 216,841 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award deriv | 2022-06-29 | 2022-07-08 | 26,900 | — | $0 | 26,900 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award deriv | 2022-02-15 | 2022-02-17 | 80,000 | — | $0 | 80,000 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award | 2022-02-15 | 2022-02-17 | 53,600 | — | $0 | 163,241 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award deriv | 2021-08-09 | 2021-08-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award deriv | 2020-12-09 | 2020-12-11 | 108,633 | — | $0 | 108,633 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award | 2020-12-09 | 2020-12-11 | 72,422 | — | $0 | 109,641 | SEC↗ |
| KRON Kronos Bio, Inc. | P Buy | 2020-10-14 | 2020-10-16 | 5,250 | $19.00 | $99.8K | 37,219 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | D To issuer deriv | 2020-05-06 | 2020-05-06 | 192,759 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | D To issuer deriv | 2020-05-06 | 2020-05-06 | 61,031 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | D To issuer deriv | 2020-05-06 | 2020-05-06 | 100,000 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | D To issuer | 2020-05-06 | 2020-05-06 | 196,965 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | F Tax w/h | 2020-02-29 | 2020-03-02 | 4,891 | $1.50 | $7.3K | 196,965 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | F Tax w/h | 2020-02-25 | 2020-02-27 | 5,385 | $1.51 | $8.1K | 201,856 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | A Award | 2020-01-12 | 2020-01-13 | 65,000 | — | $0 | 207,241 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | A Award | 2019-11-25 | 2019-11-25 | 75,000 | — | $0 | 142,241 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | A Award deriv | 2019-02-27 | 2019-03-01 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | A Award | 2019-02-27 | 2019-03-01 | 50,000 | — | $0 | 67,241 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | M Exercise deriv | 2018-07-17 | 2018-07-18 | 17,241 | — | $0 | 192,759 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | M Exercise | 2018-07-17 | 2018-07-18 | 17,241 | $5.80 | $100.0K | 17,241 | SEC↗ |
| MACK MERRIMACK PHARMACEUTICALS | A Award deriv | 2016-02-08 | 2016-02-10 | 105,000 | — | $0 | 105,000 | SEC↗ |
| MACK MERRIMACK PHARMACEUTICALS | A Award deriv | 2015-08-11 | 2015-08-13 | 300,000 | — | $0 | 300,000 | SEC↗ |